GW Pharmaceuticals Plc ADS (GWPH)

[john1311]

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational Progress

Total revenue for the quarter ended December 31, 2020 was $148.2 million compared to $109.1 million for the quarter ended December 31, 2019.

Total revenue for the full-year 2020 was $527.2 million, a 69 percent increase compared to $311.3 million for the prior year period.

Net loss for the quarter ended December 31, 2020 was $29.1 million compared to net loss of $24.9 million for the quarter ended December 31, 2019.

Cash and cash equivalents at December 31, 2020 were $486.8 million.


https://ir.gwpharm.com/news-releases/news-release-details/gw-pharmaceuticals-plc-reports-fourth-quarter-and-year-end-2020